🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Food allergy is a serious public health concern that causes potentially-lif...
Status
Completed
Location
University of California Los Angeles (UCLA)
Start Date
2020-02-05
Trial ID
NCT03679676
Treatments Being Tested
To evaluate if omalizumab is effective in decreasing mortality in severe ho...
Status
Unknown
Location
Niagara Health - St. Catharine's Sites
Start Date
2021-10-15
Trial ID
NCT04720612
Treatments Being Tested
This research is being done to study the effects of the drug omalizumab (Xo...
Status
Completed
Location
Johns Hopkins Asthma and Allergy Center
Start Date
2007-07
Trial ID
NCT00604786
Treatments Being Tested
Elevated levels of immunoglobuline E in blood are said to promote the occur...
Status
Completed
Location
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria.
Start Date
2001-10
Trial ID
NCT00822783
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of omalizumab,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01202903
Treatments Being Tested
Aim: The aim of this study was to investigate the effect of subcutaneous in...
Status
Completed
Location
University of Health Sciences
Start Date
2018-06-05
Trial ID
NCT04210323
Treatments Being Tested
The study is designed to explore the mode of action for omalizumab therapy ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01599637
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of omaliz...
Status
Completed
Location
Jonathan Corren MD, Inc.
Start Date
2017-11-15
Trial ID
NCT03280550
Treatments Being Tested
The study is a global Phase III, multicenter, randomized, double-blind, pla...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01264939